References
- Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645–1658.
- Tackling drug-resistant infections globally: final report and recommendations/the Review on Antimicrobial Resistance chaired by Jim O’Neill. 2016. Available from: https://wellcomecollection.org/works/thvwsuba
- Kwon JH, Powderly WG. The post-antibiotic era is here. Science. 2021;373:471.
- Lai -C-C, Chen S-Y, Ko W-C, et al. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021;57:106324.
- Founou RC, Blocker AJ, Noubom M, et al. The COVID-19 pandemic: a threat to antimicrobial resistance containment. Future Sci OA. 2021;7:FSO736.
- Ghosh C, Sarkar P, Issa R, et al. Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends Microbiol. 2019;27:323–338.
- Micoli F, Bagnoli F, Rappuoli R, et al. The role of vaccines in combatting antimicrobial resistance. Nature Rev Microbiol. 2021;19:287–302.
- Morel CM, Lindahl O, Harbarth S, et al. Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus. J Antibiot (Tokyo). 2020;73:421–428.
- Li Y, Tenchov R, Smoot J, et al. A comprehensive review of the global efforts on COVID-19 vaccine development. ACS Cent Sci. 2021;7:512–533.
- Olliaro P, Torreele E, Vaillant M. COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room. Lancet Microbe. 2021;2:e279–e280.
- Nasreen S, Chung H, He S, et al. Effectiveness of COVID-19 vaccines against variants of concern in Ontario, Canada. medRxiv. 2021:2021.2006.2028.21259420.
- Fan X-Y, Lowrie DB. Where are the RNA vaccines for TB? Emerg Microbes Infect. 2021;10:1217–1218.
- Wu K, Choi A, Koch M, et al. Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice. bioRxiv. 2021:2021.2004.2013.439482.
- Mallory KL, Taylor JA, Zou X, et al. Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice. Npj Vaccines. 2021;6:84.
- Xue T, Stavropoulos E, Yang M, et al. RNA encoding the MPT83 antigen induces protective immune responses against mycobacterium tuberculosis infection. Infect Immun. 2004;72:6324–6329.
- Maruggi G, Chiarot E, Giovani C, et al. Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens. Vaccine. 2017;35:361–368.
- Dolgin E. CureVac COVID vaccine let-down spotlights mRNA design challenges. Nature. 2021;594:483.
- Fuller DH, Phimister EG, Berglund P. Amplifying RNA vaccine development. N Engl J Med. 2020;382:2469–2471.